...
首页> 外文期刊>Bioorganic and medicinal chemistry >Chemical modification of the beta-glucocerebrosidase inhibitor N-octyl-beta-valienamine: synthesis and biological evaluation of 4-epimeric and 4-O-(beta-D-galactopyranosyl) derivatives.
【24h】

Chemical modification of the beta-glucocerebrosidase inhibitor N-octyl-beta-valienamine: synthesis and biological evaluation of 4-epimeric and 4-O-(beta-D-galactopyranosyl) derivatives.

机译:β-葡萄糖脑苷脂酶抑制剂N-辛基-β-戊烯胺的化学修饰:4-表异构和4-O-(β-D-吡喃半乳糖基)衍生物的合成和生物学评估。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

N-Octyl-beta-valienemine (1), a potent beta-glucocerebrosidase inhibitor, was chemically transformed into two biologically interesting compounds: the 4-epimer, beta-galacto-type N-octyl-valienamine, and the 4-O-(beta-D-galactopyranosyl) derivative, a carba-lactosylceramide analogue. The former, interestingly, could be demonstrated to act as a very effective inhibitor (IC(50)=0.3 microM) of human beta-galactosidase. The latter exhibited moderate inhibitory activity (IC(50)=20 microM) against beta-glucocerebrosidase (mouse liver).
机译:N-辛基-β-缬氨酸胺(1)是一种有效的β-葡萄糖脑苷脂酶抑制剂,已化学转化为两种生物学上有趣的化合物:4-表位,β-半乳糖型N-辛基-缬氨酸胺和4-O-( β-D-galactopyranosyl)衍生物,是一种氨基甲酸酯-乳糖基神经酰胺类似物。有趣的是,前者可被证明是人类β-半乳糖苷酶的一种非常有效的抑制剂(IC(50)= 0.3 microM)。后者表现出对β-葡萄糖脑苷脂酶(小鼠肝脏)的中等抑制活性(IC(50)= 20 microM)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号